Loading...

TECX TECTONIC THERAPEUTIC INC Expansion Plans 8-K Filing

TCTN

TCX

TECTONIC THERAPEUTIC INC

(TECX)

2025 8-K

Show Summary

Show Summary

Product Expansion

Financial Statements

Financial Results

Securities Agreement

Positive Trial Data

Corporate Update

Financial Results

Positive Trial Results

Financial Results

FDA Clearance of IND Applic...

Departure of Officer

Corporate Presentation Upda...

Management Changes

Merger Closing Delayed and ...

Merger Agreement and Revers...

Merger Approval

Merger and Litigation

Merger Presentation

Merger Agreement

Compliance with Minimum Bid...

Termination, Asset Sale, Co...

Departure of Directors or C...

Sale of Cystinosis Program

Clinical Trial Results

Financial Results

Resignation and Appointment

Earnings Reports

Compliance with Minimum Bid...

External Links:

On May 17, 2025, Tectonic Therapeutic, Inc. announced positive results from a Phase 1b clinical trial of TX45 for treating Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction at the ESC Heart Failure event.

AI Assistant

TECTONIC THERAPEUTIC INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.